| Pharmaceutical Information |
| Drug Name |
Nalbuphine |
| Drug ID |
BADD_D01519 |
| Description |
A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors. Nalbuphine is the only opioid analgesic that is not a controlled substance in the United States. |
| Indications and Usage |
For the relief of moderate to severe pain. |
| Marketing Status |
approved |
| ATC Code |
N02AF02 |
| DrugBank ID |
DB00844
|
| KEGG ID |
D08246
|
| MeSH ID |
D009266
|
| PubChem ID |
5311304
|
| TTD Drug ID |
D01KQA
|
| NDC Product Code |
Not Available |
| UNII |
L2T84IQI2K
|
| Synonyms |
Nalbuphine | Nalbuphine Hydrochloride | Nalbuphine Serb | EN-2234A | EN 2234A | EN2234A | Nubain |
|
| Chemical Information |
| Molecular Formula |
C21H27NO4 |
| CAS Registry Number |
20594-83-6 |
| SMILES |
C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
